Comparison of P53 mutation status, primary cytoreductive surgical outcomes, and overall survival in patients with ovarian cancer

David Engle; Hubert Fornalik; Traci Neff; Anna Button; K Collins; Amina Ahmed; David Bender; Susan Lutgendorf; Michael Goodheart

doi:10.17077/2154-4751.1107

Abstract

Comparison of P53 mutation status, primary cytoreductive surgical outcomes, and overall survival in patients with ovarian cancer

Authors

- David Engle
- University of Iowa View ROR record for University of Iowa. (opens in new tab)
- Hubert Fornalik
- University of Iowa View ROR record for University of Iowa. (opens in new tab)
- Traci Neff
- University of Iowa View ROR record for University of Iowa. (opens in new tab)
- Anna Button
- University of Iowa View ROR record for University of Iowa. (opens in new tab)
- K Collins
- University of Iowa View ROR record for University of Iowa. (opens in new tab)
- Amina Ahmed
- University of Iowa View ROR record for University of Iowa. (opens in new tab)
- David Bender
- University of Iowa View ROR record for University of Iowa. (opens in new tab)
- Susan Lutgendorf
- University of Iowa View ROR record for University of Iowa. (opens in new tab)
- Michael Goodheart

Abstract

Optimal surgical cytoreduction continues to be an important prognostic variable in patients with ovarian cancer independent of p53 mutational status. Among patients with suboptimal cytoreduction a p53 mutation may offer a survival advantage.

Keywords: P53, cytoreductive surgery, survival, ovarian cancer

How to Cite: Engle, D. , Fornalik, H. , Neff, T. , Button, A. , Collins, K. , Ahmed, A. , Bender, D. , Lutgendorf, S. & Goodheart, M. (2011) “Comparison of P53 mutation status, primary cytoreductive surgical outcomes, and overall survival in patients with ovarian cancer”, Proceedings in Obstetrics and Gynecology. 2(1). doi: https://doi.org/10.17077/2154-4751.1107